Moderna loses bid to patent mRNA vaccine
Moderna has failed in its bid to secure an mRNA vaccine patent, but an IP Australia delegate gave the US biotech another shot at its application.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
